Jones Financial Companies
SPRY icon

Jones Financial Companies’s ARS Pharmaceuticals SPRY Stock Holding History

Jones Financial Companies’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.3K Sell
11,040
-102
-0.9% -$877 ﹤0.01% 2880
2026
Q1 		$89.9K Sell
11,142
-998
-8% -$9.56K ﹤0.01% 2711
2025
Q4 		$141K Buy
12,140
+10,680
+732% +$104K ﹤0.01% 2072
2025
Q3 		$14.3K Buy
1,460
+125
+9% +$1.79K ﹤0.01% 2943
2025
Q2 		$24.3K Buy
+1,335
New +$19.3K ﹤0.01% 2508

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jones Financial Companies's SPRY Position: Q2 2026 in Review

Jones Financial Companies reduced its ARS Pharmaceuticals (SPRY) stake by 0.92% in Q2 2026, selling an estimated $877 and leaving 11,040 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

Jones Financial Companies first reported a position in SPRY in Q2 2025 and has held it in 5 quarters since. The position peaked at $141K in Q4 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Jones Financial Companies held 11,040 shares of ARS Pharmaceuticals worth $94.3K as of Q2 2026.
  • Jones Financial Companies sold 102 ARS Pharmaceuticals shares in Q2 2026, an estimated $877.
  • ARS Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2880 holding.
  • Jones Financial Companies first reported a position in ARS Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's ARS Pharmaceuticals position peaked at $141K in Q4 2025.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.